Redcare Pharmacy NV (LON:0RJT)

Redcare Pharmacy NV Statistics

Total Valuation

LON:0RJT has a market cap or net worth of GBP 1.32 billion. The enterprise value is 1.40 billion.

Market Cap	1.32B
Enterprise Value	1.40B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.34M
Shares Outstanding	n/a
Shares Change (YoY)	+0.98%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.58
PB Ratio	2.91
P/TBV Ratio	14.81
P/FCF Ratio	1,768.76
P/OCF Ratio	35.17
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-46.78
EV / Sales	0.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1,872.23

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.73.

Current Ratio	1.71
Quick Ratio	1.12
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	441.88
Interest Coverage	-2.28

Financial Efficiency

Return on equity (ROE) is -6.77% and return on invested capital (ROIC) is -2.57%.

Return on Equity (ROE)	-6.77%
Return on Assets (ROA)	-1.93%
Return on Invested Capital (ROIC)	-2.57%
Return on Capital Employed (ROCE)	-4.10%
Revenue Per Employee	1.26M
Profits Per Employee	-16,354
Employee Count	1,827
Asset Turnover	2.36
Inventory Turnover	13.92

Taxes

Income Tax	-5.35M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.96%
50-Day Moving Average	92.19
200-Day Moving Average	114.19
Relative Strength Index (RSI)	36.48
Average Volume (20 Days)	5,633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RJT had revenue of GBP 2.29 billion and -29.88 million in losses. Loss per share was -1.49.

Revenue	2.29B
Gross Profit	531.29M
Operating Income	-29.96M
Pretax Income	-36.34M
Net Income	-29.88M
EBITDA	-10.42M
EBIT	-29.96M
Loss Per Share	-1.49

Balance Sheet

The company has 270.62 million in cash and 329.91 million in debt, giving a net cash position of -59.29 million.

Cash & Cash Equivalents	270.62M
Total Debt	329.91M
Net Cash	-59.29M
Net Cash Per Share	n/a
Equity (Book Value)	453.06M
Book Value Per Share	21.44
Working Capital	236.40M

Cash Flow

In the last 12 months, operating cash flow was 37.55 million and capital expenditures -36.81 million, giving a free cash flow of 746,615.

Operating Cash Flow	37.55M
Capital Expenditures	-36.81M
Free Cash Flow	746,615
FCF Per Share	n/a

Margins

Gross margin is 23.16%, with operating and profit margins of -1.31% and -1.30%.

Gross Margin	23.16%
Operating Margin	-1.31%
Pretax Margin	-1.58%
Profit Margin	-1.30%
EBITDA Margin	-0.45%
EBIT Margin	-1.31%
FCF Margin	0.03%

Dividends & Yields

LON:0RJT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.98%
Shareholder Yield	n/a
Earnings Yield	-2.26%
FCF Yield	0.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RJT has an Altman Z-Score of 4.15 and a Piotroski F-Score of 4.

Altman Z-Score	4.15
Piotroski F-Score	4